Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780–6. https://doi.org/10.1038/s41415-022-5166-x.
Article PubMed PubMed Central Google Scholar
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60–72. https://doi.org/10.1056/nejmra1715715.
Article CAS PubMed Google Scholar
Alshadwi A, Nadershah M, Carlson ER, Young LS, Burke PA, Daley BJ. Nutritional considerations for head and neck cancer patients: a review of the literature. J Oral Maxillofac Surg. 2013;71:1853–60. https://doi.org/10.1016/j.joms.2013.04.028.
Zwart AT, Van Der Hoorn A, Van Ooijen PMA, Steenbakkers RJHM, De Bock GH, Halmos GB. CT‐measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. J Cachexia Sarcopenia Muscle. 2019;10:1060–9. https://doi.org/10.1002/jcsm.12443.
Article PubMed PubMed Central Google Scholar
Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–71. https://doi.org/10.1038/sj.bjc.6605578.
Article CAS PubMed PubMed Central Google Scholar
Givens DJ, Karnell LH, Gupta AK, Clamon GH, Pagedar NA, Chang KE, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Neck Surg. 2009;135:1209. https://doi.org/10.1001/archoto.2009.174.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. https://doi.org/10.1093/ageing/afy169.
Silva PB, Ramos GHA, Petterle RR, Borba VZC. Sarcopenia as an early complication of patients with head and neck cancer with dysphagia. Eur J Cancer Care. 2021;30:e13343. https://doi.org/10.1111/ecc.13343.
Shen W, Punyanitya M, Wang Z, Gallagher D, St.-Onge MP, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97:2333–8. https://doi.org/10.1152/japplphysiol.00744.2004.
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95. https://doi.org/10.1016/s1470-2045(10)70218-7.
Van Den Noortgate W, López-López JA, Marín-Martínez F, Sánchez-Meca J. Three-level meta-analysis of dependent effect sizes. Behav Res Methods. 2013;45:576–94. https://doi.org/10.3758/s13428-012-0261-6.
Van Beers MA, Speksnijder CM, Van Gils CH, Frederix GWJ, Dankbaar JW, De Bree R. Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial. BMC Cancer. 2024;24:76. https://doi.org/10.1186/s12885-023-11773-7.
Article PubMed PubMed Central Google Scholar
Schaeffers AWMA, Devriese LA, Van Gils CH, Dankbaar JW, Voortman J, De Boer JP, et al. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: the CISLOW-study protocol. PLOS One. 2023;18:e0294147. https://doi.org/10.1371/journal.pone.0294147.
Article CAS PubMed PubMed Central Google Scholar
Molenaar CJL, Minnella EM, Coca-Martinez M, Ten Cate DWG, Regis M, Awasthi R, et al. Effect of multimodal prehabilitation on reducing postoperative complications and enhancing functional capacity following colorectal cancer surgery: the PREHAB randomized clinical trial. JAMA Surg. 2023;158:572. https://doi.org/10.1001/jamasurg.2023.0198.
Article PubMed PubMed Central Google Scholar
Loewen I, Jeffery CC, Rieger J, Constantinescu G. Prehabilitation in head and neck cancer patients: a literature review. J Otolaryngol Head Neck Surg. 2021;50:2. https://doi.org/10.1186/s40463-020-00486-7.
Article PubMed PubMed Central Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. https://doi.org/10.1136/bmj.n71
Hayden JA, Van Der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280. https://doi.org/10.7326/0003-4819-158-4-201302190-00009.
McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55–61. https://doi.org/10.1002/jrsm.1411.
Geeraert L, Van Den Noortgate W, Grietens H, Onghena P. The effects of early prevention programs for families with young children at risk for physical child abuse and neglect: a meta-analysis. Child Maltreat. 2004;9:277–91. https://doi.org/10.1177/1077559504264265.
Van Den Noortgate W, López-López JA, Marín-Martínez F, Sánchez-Meca J. Meta-analysis of multiple outcomes: a multilevel approach. Behav Res Methods. 2015;47:1274–94. https://doi.org/10.3758/s13428-014-0527-2.
Achim V, Bash J, Mowery A, Guimaraes AR, Li R, Schindler J, et al. Prognostic indication of sarcopenia for wound complication after total laryngectomy. JAMA Otolaryngol Neck Surg. 2017;143:1159. https://doi.org/10.1001/jamaoto.2017.0547.
Ahern E, Brown TE, Campbell L, Hughes BGM, Banks M, Lin CY, et al. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment. Br J Nutr. 2023;129:406–15. https://doi.org/10.1017/s0007114522000435.
Article CAS PubMed Google Scholar
Alwani MM, Jones AJ, Novinger LJ, Pittelkow E, Bonetto A, Sim MW, et al. Impact of sarcopenia on outcomes of autologous head and neck free tissue reconstruction. J Reconstr Microsurg. 2020;36:369–78. https://doi.org/10.1055/s-0040-1701696.
Ansari E, Chargi N, Van Gemert JTM, Van Es RJJ, Dieleman FJ, Rosenberg AJWP, et al. Low skeletal muscle mass is a strong predictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap. Oral Oncol. 2020;101:104530. https://doi.org/10.1016/j.oraloncology.2019.104530.
Article CAS PubMed Google Scholar
Ansari E, Chargi N, Van Es RJJ, Dieleman FJ, Van Cann EM, De Bree R. Association of preoperative low skeletal muscle mass with postoperative complications after selective neck dissection. Int J Oral Maxillofac Surg. 2022;51:1389–93. https://doi.org/10.1016/j.ijom.2022.02.008.
Article CAS PubMed Google Scholar
Arribas L, Plana M, Taberna M, Sospedra M, Vilariño N, Oliva M, et al. Predictive value of skeletal muscle mass in recurrent/metastatic head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors. Front Oncol. 2021;11:699668. https://doi.org/10.3389/fonc.2021.699668.
Article CAS PubMed PubMed Central Google Scholar
Bardoscia L, Besutti G, Pellegrini M, Pagano M, Bonelli C, Bonelli E, et al. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation. Front Nutr. 2022;9:994499. https://doi.org/10.3389/fnut.2022.994499.
Article PubMed PubMed Central Google Scholar
Becker JN, Hermann R, Wichmann J, Sonnhoff M, Christiansen H, Bruns F. Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy. PLOS One. 2023;18:e0282015. https://doi.org/10.1371/journal.pone.0282015.
Article CAS PubMed PubMed Central Google Scholar
Bentahila R, Giraud P, Decazes P, Kreps S, Nay P, Chatain A, et al. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy. Cancer Med. 2023;12:4170–83. https://doi.org/10.1002/cam4.5278.
Comments (0)